The gastrointestinal tract: properties and role in allogeneic hematopoietic stem cell transplantation

被引:8
作者
Pessach, Ilias [1 ]
Tsirigotis, Panagiotis [1 ]
Nagler, Arnon [2 ]
机构
[1] Natl & Kapodistrian Univ Athens, ATTIKO Univ Hosp, Div Hematol, Dept Internal Med 2, Athens, Greece
[2] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, Tel Hashomer, Israel
关键词
GI-tract; allo-HSCT; GVHD; paneth cells; Mast Cells (MCs); Innate Lymphoid Cells (ILCs); Antigen Presenting Cells (APCs); Toll-like receptors (TLRs); NOD-like receptors (NLRs); intestinal microbiota; VERSUS-HOST-DISEASE; INNATE LYMPHOID-CELLS; ESCHERICHIA-COLI STRAINS; NECROSIS-FACTOR-ALPHA; CHAIN FATTY-ACIDS; IMMUNE-RESPONSES; DENDRITIC CELLS; INTESTINAL MICROBIOTA; SECONDARY DISEASE; GUT MICROBIOTA;
D O I
10.1080/17474086.2017.1288566
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The GI-tract is a major target for both the intensive chemo and/or radiotherapy conditioning as well as for GVHD and therefore is closely associated with transplant outcome. Apart from being a target, the GI-tract is also a mediator and therefore is also a key player of the pathogenetic process following allogeneic transplantation.Areas covered: The intestinal homeostasis is regulated through complicated interactions between the key players of this process which are the intestinal epithelium, the intestinal immune system, and the intestinal microbiota. A brief description of these elements, based on published english-language articles in PubMed, as well as their role during the process of allo-HSCT is discussed in this review.Expert commentary: Data on GI-tract properties suggest a central role for the intestine in regulation of immunity, both in healthy - steady state conditions and in pathological states such as during allo-HSCT. Given the fact that in the allogeneic transplant setting severe complications such as infections and GVHD are limiting this treatment modality, understanding the mechanisms that mediate intestinal homeostasis could lead to new preventive methods and improved outcomes.
引用
收藏
页码:315 / 326
页数:12
相关论文
共 112 条
  • [1] [Anonymous], RECENT ADV GERM FREE
  • [2] Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
    Atarashi, Koji
    Tanoue, Takeshi
    Shima, Tatsuichiro
    Imaoka, Akemi
    Kuwahara, Tomomi
    Momose, Yoshika
    Cheng, Genhong
    Yamasaki, Sho
    Saito, Takashi
    Ohba, Yusuke
    Taniguchi, Tadatsugu
    Takeda, Kiyoshi
    Hori, Shohei
    Ivanov, Ivaylo I.
    Umesaki, Yoshinori
    Itoh, Kikuji
    Honda, Kenya
    [J]. SCIENCE, 2011, 331 (6015) : 337 - 341
  • [3] Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria
    Ayabe, T
    Satchell, DP
    Wilson, CL
    Parks, WC
    Selsted, ME
    Ouellette, AJ
    [J]. NATURE IMMUNOLOGY, 2000, 1 (02) : 113 - 118
  • [4] Muc2 Protects against Lethal Infectious Colitis by Disassociating Pathogenic and Commensal Bacteria from the Colonic Mucosa
    Bergstrom, Kirk S. B.
    Kissoon-Singh, Vanessa
    Gibson, Deanna L.
    Ma, Caixia
    Montero, Marinieve
    Sham, Ho Pan
    Ryz, Natasha
    Huang, Tina
    Velcich, Anna
    Finlay, B. Brett
    Chadee, Kris
    Vallance, Bruce A.
    [J]. PLOS PATHOGENS, 2010, 6 (05)
  • [5] Human type 1 innate lymphoid cells accumulate in inflamed mucosa! tissues
    Bernink, Jochem H.
    Peters, Charlotte P.
    Munneke, Marius
    te Velde, Anje A.
    Meijer, Sybren L.
    Weijer, Kees
    Hreggvidsdottir, Hulda S.
    Heinsbroek, Sigrid E.
    Legrand, Nicolas
    Buskens, Christianne J.
    Bemelman, Willem A.
    Mjosberg, Jenny M.
    Spits, Hergen
    [J]. NATURE IMMUNOLOGY, 2013, 14 (03) : 221 - 229
  • [6] Fecal Microbiota Transplantation Inhibits Multidrug-Resistant Gut Pathogens: Preliminary Report Performed in an Immunocompromised Host
    Bilinski, Jaroslaw
    Grzesiowski, Pawel
    Muszynski, Jacek
    Wroblewska, Marta
    Madry, Krzysztof
    Robak, Katarzyna
    Dzieciatkowski, Tomasz
    Wiktor-Jedrzejczak, Wieslaw
    Basak, Grzegorz W.
    [J]. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2016, 64 (03) : 255 - 258
  • [7] Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data
    Bischoff, Stephan C.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2007, 7 (02) : 93 - 104
  • [8] Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT)
    Blazar, Bruce R.
    Weisdorf, Daniel J.
    Defor, Todd
    Goldman, Anne
    Braun, Thomas
    Silver, Samuel
    Ferrara, James L. M.
    [J]. BLOOD, 2006, 108 (09) : 3216 - 3222
  • [9] Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology
    Buonocore, Sofia
    Ahern, Philip P.
    Uhlig, Holm H.
    Ivanov, Ivaylo I.
    Littman, Dan R.
    Maloy, Kevin J.
    Powrie, Fiona
    [J]. NATURE, 2010, 464 (7293) : 1371 - 1375
  • [10] Critical Role of TLR9 in Acute Graft-versus-Host Disease
    Calcaterra, Claudia
    Sfondrini, Lucia
    Rossini, Anna
    Sommariva, Michele
    Rumio, Cristiano
    Menard, Sylvie
    Balsari, Andrea
    [J]. JOURNAL OF IMMUNOLOGY, 2008, 181 (09) : 6132 - 6139